Dubai : Merck, a leading science and technology company, has taken part in the sixth Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) congress. The data, which includes the statistics on MS patients from the UAE, Oman, and Kuwait, was presented during the congress. Dr. Matthias Meergans, Medical Head, MEAR, at Merck Healthcare said: “We are committed to serving the region’s MS patients. Whenever possible, we collaborate with organizations and companies such as Merck, who support and enhance our mission. Merck holds the global rights to the Merck name and brand.

Source: The North Africa Journal December 12, 2021 17:02 UTC